BioSig amends 8-K to provide Streamex business overview, risk factors, and pro forma financials

Streamex Corp.

Streamex generated ~$200,000 revenue in Q1 2025; platform still under development with no tokenized assets launched.
Streamex to tokenize real-world assets starting with gold; competes with Pax Gold ($810M cap) and Securitize ($4B+ tokenized).
BioSig now operates two segments: healthcare (PURE EP/ViralClear) and tokenized finance through Streamex.
Streamex holds minority interest in Canadian Exempt Market Dealer license; tokens likely classified as securities.
Pro forma combined financials filed for periods ended March 31, 2025 and December 31, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.